BetterLife Pharma (BETRF) Asset Writedowns and Impairment (2019 - 2021)

BetterLife Pharma's Asset Writedowns and Impairment history runs 3 years deep, the most recent figure standing at -$964936.9 for Q1 2021.

• In Q1 2021, Asset Writedowns and Impairment fell 13830.89% year-over-year to -$964936.9; the TTM figure through Jan 2021 stood at -$1.5 million (down 38229.8% YoY), while the FY2021 annual figure was -$9.1 million, down 81.21% from the prior year.
• Asset Writedowns and Impairment for Q1 2021 stood at -$964936.9, down from -$519788.1 in the prior quarter.
• The five-year high for Asset Writedowns and Impairment was $2930.9 in Q2 2019, with the low at -$964936.9 in Q1 2021.
• The 3-year median for Asset Writedowns and Impairment is -$39875.8 (2020), against an average of -$305719.3.
• Peak annual rise in Asset Writedowns and Impairment reached 13830.89% in 2021, while the deepest fall reached 13830.89% in 2021.
• BetterLife Pharma's Asset Writedowns and Impairment stood at $2930.9 in 2019, then plunged by 17834.51% to -$519788.1 in 2020, then sank by 85.64% to -$964936.9 in 2021.
• Business Quant data shows BETRF's Asset Writedowns and Impairment at -$964936.9 in Q1 2021, -$519788.1 in Q4 2020, and -$39875.8 in Q3 2020.